▲ +82.62% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Charlotte's Web in the last 3 months. The average price target is $7.25, with a high forecast of $13.00 and a low forecast of $4.00. The average price target represents a 82.62% upside from the last price of $3.97.
The current consensus among 4 polled investment analysts is to buy stock in Charlotte's Web. This Buy consensus rating has held steady for over two years.
Charlotte's Web Holdings, Inc. produces and distributes hemp-based cannabidiol wellness products in the United States. The company offers products in the categories of tinctures, capsules, gummies, topicals, and pet products. It distributes its products under the Charlotte's Web name through its e-commerce website, third party e-commerce websites, as well as distributors, health practitioners, and various brick and mortar retailers. Charlotte's Web Holdings, Inc. has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was incorporated in 2018 and is headquartered in Boulder, Colorado.